688363 華熙生物
按盤價 
63.390 +1.600 (+2.589%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.469 | 8.728 | 15.745 | 14.597 | 13.497 |
| 總資產報酬率 ROA (%) | 2.900 | 6.910 | 11.997 | 11.835 | 12.085 |
| 投入資產回報率 ROIC (%) | 3.358 | 8.259 | 14.678 | 13.979 | 13.390 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.731 | 73.320 | 76.990 | 78.066 | 81.408 |
| 營業利潤率 (%) | 22.074 | 11.659 | 17.869 | 18.302 | 28.755 |
| 息稅前利潤/營業總收入 (%) | 21.751 | 11.042 | 17.101 | 17.982 | 28.806 |
| 淨利潤/營業總收入 (%) | 17.889 | 9.591 | 15.118 | 15.675 | 24.500 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.718 | 90.875 | 91.276 | 87.827 | 93.194 |
| 價值變動淨收益/利潤總額(%) | -0.529 | 0.398 | 1.036 | 3.150 | 4.944 |
| 營業外收支淨額/利潤總額(%) | 0.095 | -0.950 | -0.018 | -1.725 | 0.244 | 償債能力分析 |
| 流動比率 (X) | 3.146 | 2.558 | 2.447 | 2.845 | 6.626 |
| 速動比率 (X) | 1.860 | 1.629 | 1.741 | 2.338 | 5.764 |
| 資產負債率 (%) | 14.287 | 17.551 | 23.023 | 24.005 | 12.223 |
| 帶息債務/全部投入資本 (%) | -1.327 | 0.173 | 3.478 | 2.381 | -1.451 |
| 股東權益/帶息債務 (%) | -7,339.555 | 55,551.426 | 2,675.714 | 3,924.090 | -6,794.689 |
| 股東權益/負債合計 (%) | 596.603 | 467.119 | 331.894 | 316.387 | 718.383 |
| 利息保障倍數 (X) | -63.281 | -21.787 | -22.350 | -1,798.523 | -1,482.564 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 33.653 | 26.538 | 23.920 | 27.976 | 50.866 |
| 存貨周轉天數 (天) | 312.758 | 254.954 | 230.122 | 196.693 | 290.987 |
| 備註： | 即時報價更新時間為 17/05/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
